Mereo BioPharma MREO
NASDAQ MREO
$0.28 -0.01 (-3.45%)
At close: Oct 23, 2026 · 4:00 PM EDT

Mereo BioPharma (MREO) Price to Sales (2023 - 2026)

Updated

Mereo BioPharma's Price to Sales was 102.20 in Q2 2026, down 88.1% from 862.31 a year earlier.

Analysis

Mereo BioPharma (MREO) Price to Sales (2023 - 2026) Analysis & Trends

For FY2025, Price to Sales at Mereo BioPharma came in at 134.08.

  • In earlier years, Price to Sales was 32.40 in FY2023 and 3.81 in FY2021.
  • The Q2 2026 figure marks the lowest quarterly Price to Sales since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Mereo BioPharma 44.71 Mn -105.20 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4,645.56
Mar 31, 2026 103.08
Dec 31, 2025 209.50
Sep 30, 2025 1,024.41
Jun 30, 2025 1,347.35
Sep 30, 2024 637.65
Jun 30, 2024 553.87
Mar 31, 2024 46.29
Dec 31, 2023 32.40
API Access

Mereo BioPharma Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=MREO&period=max&api_key=YOUR_API_KEY